A First in Human Study of theMenin-KMT2A (MLL1)Inhibitor JNJ-75276617 in Participants with Acute Leukemia

Go Back to All Clinical Trials

A First in Human Study of theMenin-KMT2A (MLL1)Inhibitor JNJ-75276617 in Participants with Acute Leukemia

Brief description of study

Clinical Study Identifier: s21-00051

ClinicalTrials.gov Identifier: NCT04811560

Principal Investigator: Mohammad Maher Abdul Hay.

Other Investigators: Ashley Pinchinat, Dimitrios Papaioannou, Kenny Tai, Gabrielle C Barshay, William L Carroll, Jingmei Hsu, Kirsty Hillier, Caitlin Elizabeth Ryan, Nicole Mallory, Gloria Paz Contreras Yametti, Jessica Clymer, Elizabeth A Raetz, Jun Han Choi, Shella Saint Fleur-Lominy, Gabriel Andrew Robbins, Elizabeth Ann Roman.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies